I don't think you can presume that 3M are paying OBJ for the evaluation of their product. I they were OBJ would have to declare this to the market, like they did when GSK paid $235K for their evaluation of the product. Anything relating to income derived by the company and is sensitive to the market must be divulged.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable